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Abstract
Ischemia/reperfusion injury (IRI) is a leading cause of acute renal failure. The definition of the molecular mechanisms
involved in renal IRI and counter protection promoted by ischemic pre-conditioning (IPC) or Hemin treatment is an
important milestone that needs to be accomplished in this research area. We examined, through an oligonucleotide
microarray protocol, the renal differential transcriptome profiles of mice submitted to IRI, IPC and Hemin treatment. After
identifying the profiles of differentially expressed genes observed for each comparison, we carried out functional
enrichment analysis to reveal transcripts putatively involved in potential relevant biological processes and signaling
pathways. The most relevant processes found in these comparisons were stress, apoptosis, cell differentiation, angiogenesis,
focal adhesion, ECM-receptor interaction, ion transport, angiogenesis, mitosis and cell cycle, inflammatory response,
olfactory transduction and regulation of actin cytoskeleton. In addition, the most important overrepresented pathways were
MAPK, ErbB, JAK/STAT, Toll and Nod like receptors, Angiotensin II, Arachidonic acid metabolism, Wnt and coagulation
cascade. Also, new insights were gained about the underlying protection mechanisms against renal IRI promoted by IPC
and Hemin treatment. Venn diagram analysis allowed us to uncover common and exclusively differentially expressed genes
between these two protective maneuvers, underscoring potential common and exclusive biological functions regulated in
each case. In summary, IPC exclusively regulated the expression of genes belonging to stress, protein modification and
apoptosis, highlighting the role of IPC in controlling exacerbated stress response. Treatment with the Hmox1 inducer
Hemin, in turn, exclusively regulated the expression of genes associated with cell differentiation, metabolic pathways, cell
cycle, mitosis, development, regulation of actin cytoskeleton and arachidonic acid metabolism, suggesting a pleiotropic
effect for Hemin. These findings improve the biological understanding of how the kidney behaves after IRI. They also
illustrate some possible underlying molecular mechanisms involved in kidney protection observed with IPC or Hemin
treatment maneuvers.
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Introduction
Ischemia/reperfusion injury (IRI) is a leading cause of acute
renal failure (ARF), a common renal disease that is still associated
with high mortality, despite significant advances in the healthcare
system [1]. IRI is caused by a sudden transient drop in blood flow
associated with a robust inflammatory and oxidative stress
response to hypoxia and reperfusion, frequently occurring during
shock, sepsis and transplantation [2]. Although important findings
have been made in the definition of the cell biologic consequences
of IRI [3,4], there are still few therapies available for this clinical
problem [5].
It is known that renal tubular cells response to IRI depends on
the intensity and time period of ischemia. Also, many cell
phenomena such as proliferation, dedifferentiation, loss of cell
polarity and cell death are on tracking during renal IRI [6].
However, the underlying mechanisms participating in the adaptive
response occurred along renal IRI need to be clarified in order to
understand how to ameliorate the harmful consequences of IRI.
The kidney has the ability to be preconditioned by a non-lethal
period of ischemia, which makes it refractory to subsequent
ischemia-induced dysfunction in animal models [7]. The ischemic
pre-conditioning (IPC) refers to brief episodes of ischemia followed
by prolonged ischemia and reperfusion, which protects organs
PLOS ONE | www.plosone.org 1 November 2012 | Volume 7 | Issue 11 | e49569
against IRI. This phenomenon can be very useful to understand
how kidney uses an endogenous process to protect itself against
IRI, revealing whether exogenous influences can mimic this
process and, hence, alter the progress of renal acute failure [8].
The kidney can also be protected against IRI by the up-
regulation of cytoprotective proteins. For instance, the hyper-
expression of the protein heme oxygenase-1 (Hmox1), an isoform
of the enzyme involved in the degradation of heme, has shown
cytoprotective effects by its end by-products actions as anti-
oxidant, anti-inflammatory, anti-apoptotic and anti-proliferative
[9]. Indeed, recent studies have highlighted that Hmox1 induction
with the drug Hemin is protective in acute and chronic renal
insults [10,11,12]. Nevertheless, the whole mechanism of action of
Hemin is currently poorly understood, and, thus, must be well
investigated.
The knowledge of the molecular basis of diseases was facilitated
by the advances of high throughput functional genomics, allowing
deep analysis of genome-wide results [13]. In this sense, DNA
microarray technology can be used to study a complex disease, as
it offers the advantage of analyzing thousands of genes simulta-
neously. This technology coupled with bioinformatics tools may
detect changes in genes previously unknown to participate in
diseases, identifying possible altered biological functions and
providing new drug targets to be investigated. Given this
landscape, comparing in what way IPC and Hemin treatment
can protect the kidney against IRI could be a relevant approach to
analyze which mechanisms are involved in these maneuvers.
Based on that, the aim of the present work was to investigate the
differential gene expression patterns associated with renal IRI, IPC
and Hemin treatment. In addition, gene expression profiles
identified for each case were submitted to functional enrichment
analysis and a comprehensive literature review was performed to
map the state of the art regarding the biological functions
overrepresented here.
Results and Discussion
Study Design and Analysis
According to surgery and treatment procedures, mice were
divided into five groups: Control, IRI, animals pre-treated with
Hemin followed by IRI (Hemin + IRI), animals only treated
with Hemin (Hemin) and animals pre-conditioned and submit-
ted to IRI (IPC+IRI). Serum creatinine was measured in the
groups to verify whether IRI condition has compromised renal
function and if IPC and Hemin treatment were able to avoid
renal dysfunction (Figure 1). To identify the consequences of
IRI, Hemin treatment or IPC in gene expression profile, the
following statistical comparisons were made between the groups:
IRI vs Control, IPC+IRI vs Control, IPC+IRI vs IRI,
IRI+Hemin vs IRI and Hemin vs Control. These comparisons
are described in terms of data and biologically meaningful
results obtained hereafter.
IRI Versus Control
After statistical testing procedures, removal of the transcripts
with no Entrez gene ID and fold change cutoff (Fold $3 for up-
regulated genes and Fold $2 for down-regulated genes), we
identified a set of 483 differentially up-regulated and 361 down-
regulated genes as a result of IRI. These genes were submitted to
functional enrichment analysis through GO (Gene Ontology) and
KEGG (Kyoto Encyclopedia Genes and Genomes) databases, and
the main biological functions overrepresented are shown in
Figure 2. Interestingly, some of the most up-regulated genes in
terms of fold change (Table S1 - Cdkn1a, Serpine1, Hmox1, Ccl2
and Plaur) participate of the hypoxia inducible factor-1 (HIF-1)
signaling pathway, the master regulator of cellular adaptive
responses to hypoxia during IRI, which was shown elsewhere to
protect the kidney against this injury through, for example,
ischemia-induced angiogenesis [14]. In fact, many genes tran-
scriptionally controlled by HIF and involved in angiogenesis were
upregulated after IRI (Table S6– Angiogenesis). Also of note, some
genes that are regulated by Protease-Activated Receptor-2 (PAR2)
activation such as Fosl1, Serpin1 and Tnfrsf12a are present in
Table S1. PAR2 has been implicated with regulation of cytokines
and inflammatory condition, in genetic knockout mice studies
[15]. During IRI, proteases released from different sources (i.e.
inflammatory cells) can activate or up-regulate PAR2. PAR2
agonists have been shown to enhance the efficiency of ischemic
preconditioning in the heart [16] and to improve myocardial
functional recovery after IRI [17]. Hence, this protein can be a
possible relevant target to study in renal ischemic-related diseases,
due to its potential protective activity.
IPC+IRI Versus IRI
During the preconditioning period of ischemia, many inflam-
matory trigger substances can be released. These substances bind
to membrane receptors and activate intracellular signaling
cascades, which, at the end, protect the kidney against IRI. To
gain insight into the mechanism of IPC protection in the kidney,
we compared the groups IPC and IRI to understand which genes,
biological processes and signaling pathways can be possibly
involved in it. After statistical testing procedures, removal of the
transcripts with no Entrez gene ID and fold change cutoff (genes
with fold change $3), we found a set of 248 up and 24 down-
regulated genes differentially expressed due to IPC. These genes
were functionally enriched in significant biological themes,
according to Figure 3 or Tables S8 and S9. The most 25 up
and 24 down-regulated genes found here are presented in Table
S2.
Figure 1. Mean ± standard deviation of serum creatinine
concentrations found in mice submitted to different experi-
mental manipulations. C57BL/6 male mice were subjected to
surgical and treatment procedures as per described in Materials and
Methods. Levels of serum creatinine were measured using the modified
Jaffe´ technique. *Groups were statistically compared using ANOVA
followed by Tukey’s post hoc test with p,0.05.
doi:10.1371/journal.pone.0049569.g001
Renal IRI Transcriptome
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Figure 2. Top ranked biological functions after renal ischemia/reperfusion injury. A) KEGG categories showing significant enriched
functions for differentially expressed genes at IRI vs Control comparison; B) Biological Process Ontology (GO) of the differentially expressed genes
observed at IRI vs Control comparison. The bar plot represents the percentage of genes differentially expressed and functionally annotated in isolated
kidney tissue. Bar plot colors represent up (red) and down (green) regulated genes.
doi:10.1371/journal.pone.0049569.g002
Renal IRI Transcriptome
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IPC+IRI Versus Control
The comparison between IPC and Control groups was
performed to evaluate the gene expression differences between
animals submitted to ischemic pre-conditioning followed by IRI
and control conditions. After statistical testing procedures, removal
of the transcripts with no Entrez gene ID and fold change cutoff
(fold change $4 for up-regulated genes and fold change $2 for
down-regulated genes), we found a set of 564 up-regulated genes
and 115 down-regulated genes differentially expressed due to
IPC+IRI conditions. These genes were functionally enriched in
significant biological themes, according to Figure 4 or Tables S10
and S11. It is worth noting that our findings in the renal model of
IPC are in accordance with those observed in an IPC model using
adult rat hippocampal slice cultures [18]. In both cases, genes
pertaining to signaling pathways such as MAPK, Wnt, ErbB and
Toll-like receptor were up-regulated. This suggests that possibly
the same mechanisms can be observed for IPC in different organs
or experimental models. The 25 most up- regulated genes and the
25 most down- regulated genes obtained in this comparison are
listed in Table S3.
IRI + Hemin Versus IRI
Hemin is capable of reversing renal tubule-interstitial fibrosis
[19], a process involved in the renal failure outcome. Although the
role of Hemin in the modulation of oxidative stress and
inflammation was already described, a broad picture of the
molecular mechanisms involved in this protection must be
addressed. With this order, IRI+Hemin and IRI groups were
compared to establish which genes, pathways and biological
processes were modulated by Hemin treatment. After statistical
testing procedures and removal of the transcripts with no Entrez
gene ID, we identified a set of 306 up-regulated and 29 down-
regulated genes as a result of Hemin treatment before IRI. These
genes were functionally enriched in some main biological themes,
according to Figure 5. For the up-regulated genes set, the most
relevant overrepresented biological functions were regulation of
transcription, development, mitosis, response to metal ion,
regulation of cell differentiation, protein localization, hormone-
mediated signaling pathway, RNA transport, vascular smooth
muscle contraction, Wnt signaling pathway, arachidonic acid
metabolism and amino acid metabolism. For the down-regulated
genes set, the most relevant overrepresented biological functions
were apoptosis, actin filament bundle assembly, actin cytoskeleton
organization, regulation of cell proliferation, protein transport,
response to hipoxia, sodium ion transport, toll-like receptor
signaling pathway, synthesis and degradation of ketone bodies
and circadian rhythm. The 25 most up-regulated genes and the 25
most down-regulated genes obtained in this comparison are posed
in the Table S4.
Hemin Versus Control
The previous induction of Hmox1 in renal tissue is a manner of
reducing the subsequent deleterious outcomes of an IRI challenge
[20]. Aiming at evaluating the genes, pathways and biological
processes involved in this observed better response against IRI, a
comparison between Hemin and Control groups was carried out.
After statistical testing procedures, removal of the transcripts with
no Entrez gene ID and fold change cutoff (genes with fold change
$3), we found 346 up-regulated genes due to Hemin treatment.
These genes were functionally enriched in some main biological
themes, according to Figure 6. The most relevant overrepresented
biological functions were regulation of transcription, development,
cell cycle, regulation of signal transduction, DNA repair,
MAPKKK cascade, regulation of cell differentiation, RNA
splicing, coagulation cascade and amino acid metabolism. The
25 most up-regulated genes found in this comparison are listed in
the Table S5.
Transcriptome Responses Reveal the Main Biological
Functions Modulated by IRI, IPC and Hemin
We discuss hereafter the main cellular phenomena modulated
by IRI, IPC and Hemin treatment according to our data. These
overrepresented biological functions may explain some protection
mechanisms by which IPC and Hemin treatment are able of
preserving renal functions after ischemic stress. Also interestingly,
mice submitted to IRI showed differential expression of genes
belonging not just to harmful but also to putative protective
biological functions. This reveals that the transcriptome program
induced by ischemia may be also relevant to counter protection
against IRI.
Stress response. Stress response was overrepresented after
IRI and IPC conditions (Tables S6 and S10, respectively),
highlighting the relevance of dealing with cell stress under hypoxic
conditions. Highly differentially expressed genes observed here
after IRI (Table S1) and IPC+IRI (Table S3), such as ATF3 and
CHAC1, are expressed in response to eIF2a phosphorylation, a
common pathway involved in the response to a variety of stresses.
It has been demonstrated that eIF2a phosphorylation controls the
commitment to apoptosis during osmotic stress, a kind of stress
experienced in IRI [21,22], and that ATF3 functions as a
protector gene against IRI [22]. Furthermore, hypoxia experi-
enced in IRI causes protein synthesis inhibition by activating the
unfolded protein response (UPR), an adaptive signaling pathway
that promotes cell survival upon accumulation of unfolded
proteins in the endoplasmic reticulum (ER). Translation inhibition
during this event is caused by eIF2a phosphorylation through its
kinase PERK (Protein kinase-like endoplasmic reticulum kinase),
present in the ER [23]. In contrast to acute adaptive UPR
activation, chronic activation increases expression of proapoptotic
mediators, leading to massive apoptosis of kidney cells [24].
Apoptosis. We found here that genes belonging to p53
signaling and apoptosis were differentially expressed in IRI,
IPC+IRI and IRI+Hemin groups, highlighting the relevance of
apoptosis modulation after stress events. Apoptosis of renal tubular
epithelial cells plays a major role in acute renal failure [25], since
exposure to cellular stress triggers the p53 tumor suppressor factor
to induce cell growth arrest or apoptosis. p53 signaling is an
important player in the variation of tubular epithelial cells after
kidney IRI [26] and p53 inhibitors are capable of protecting
kidney against IRI [27,28]. Moreover, p53 activation mitigates the
concomitant activation of protective HIF signaling after IRI, and,
thus, the balance between the HIF-1 and p53 responses can
determine the IRI outcome [29].
MAPK pathway. As depicted in Figure 2, mitogen-activated
protein kinase (MAPK) signaling was the most overrepresented
theme after IRI. MAPKs mediate the cells response to a wide
Figure 3. Top ranked biological functions associated with renal ischemic pre-conditioning. A) KEGG categories showing significant
enriched functions for differentially expressed genes at IPC+IRI vs IRI comparison; B) Biological Process Ontology (GO) of the differentially expressed
genes observed at IPC+IRI vs IRI comparison. The bar plot represents the percentage of genes differentially expressed and functionally annotated in
isolated kidney tissue. Bar plot colors represent up (red) and down (green) regulated genes.
doi:10.1371/journal.pone.0049569.g003
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Figure 4. Top ranked biological functions after renal ischemic pre-conditioning and ischemia/reperfusion injury. A) KEGG categories
showing significant enriched functions for differentially expressed genes at IPC+IRI vs Control comparison; B) Biological Process Ontology (GO) of the
differentially expressed genes at IPC+IRI vs Control comparison. The bar plot represents the percentage of genes differentially expressed and
functionally annotated in isolated kidney tissue. Bar plot colors represent up (red) and down (green) regulated genes.
doi:10.1371/journal.pone.0049569.g004
Renal IRI Transcriptome
PLOS ONE | www.plosone.org 6 November 2012 | Volume 7 | Issue 11 | e49569
Figure 5. Top ranked biological functions after renal ischemia/reperfusion injury in mice that received previous hemin treatment.
A) KEGG categories showing significant enriched functions for differentially expressed genes at IRI+Hemin vs IRI comparison; B) Biological Process
Ontology (GO) of the differentially expressed genes at IRI+Hemin vs IRI comparison. The bar plot represents the percentage of genes differentially
expressed and functionally annotated in isolated kidney tissue. Bar plot colors represent up (red) and down (green) regulated genes.
doi:10.1371/journal.pone.0049569.g005
Renal IRI Transcriptome
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variety of physiological and stress-related stimuli, including heat
shock, ischemia, oxygen free radicals and hyperosmolality, all
stresses experienced in IRI. MAPKs activities including JNK, p38
and ERK have been suggested to be markedly enhanced after
ischemia in vivo. In addition, the relative extent of JNK, p38 or
ERK activation has been proposed to determine cell fate after
injury (cell survival, necrosis or apoptosis) in post-ischemia/
reperfusion [30]. Therefore, MAPK activation can determine
renal epithelial cell survival during oxidative injury, and the
differences in cellular outcome of the various nephron regions may
be related to specific activation of different MAPKs [31]. Also,
MAPK pathway intimately participates of the downstream signal
transduction associated with innate immune response and
subsequent proinflammatory cytokine production. Thus, the
balanced regulation of this biochemical pathway is quite relevant
to carefully control the inflammation environment created by IRI
[32].
The activity of p38 MAPK, JNK and ERK1/2, as well as
several enzymes up- and downstream of these pathways, is
regulated by their phosphorylation status. Moreover, a complex
network of negative regulatory mechanisms present in MAPK
signaling prevents deleterious effects of innate immune response.
Part of this feedback mechanism is associated with inactivation of
MAPKs by phosphatases [33]. Notably, many MAPK signaling
phosphatases were found here to be overexpressed after IRI (Table
S6– MAPK pathway). The important class of dual specificity
phosphatases (DUSP) was remarkably upregulated, showing the
relevance of this class of enzymes to regulate MAPK signaling in
this context. Also relevant, MAPK signaling was the most up-
regulated functionally enriched function observed in the compar-
ison IPC+IRI vs Control. Indeed, some studies have already
addressed the activation of MAPK signaling by IPC and IRI
[34,35]. Moreover, after Hemin treatment (Hemin x Control),
MAPKKK cascade was also one of the overrepresented themes.
Taken these multiple lines of evidence together, one can speculate
that the attenuation of renal damage effects by MAPKs is an
important agenda for future research, which should be fully
explored.
Innate immune response and JAK/STAT
signaling. Trafficking of major innate immunity cellular
components into post-ischemic kidneys is stimulated by the
expression of several chemokines. For instance, CCL2 and
CXCL1 (up-regulated genes, Table S1 and Table S3) respectively
attract macrophages and neutrophils to the injury site. Also, the
release of pro-inflammatory cytokines such as IL-6, TNF-a and
IL-1b mediates innate immune function at the local site of IRI.
Many genes encoding for these cytokines were found to be up-
regulated in our study, as summarized in the theme ‘‘Cytokine-
cytokine receptor interaction’’ (Figure 2). Moreover, the pro-
inflammatory JAK/STAT signaling pathway was overrepresented
by KEGG analysis (Figure 1). In fact, a study has demonstrated
the involvement of JAK/STAT signaling in the pathogenesis of
renal IRI, with its blockage resulting in attenuation of renal
damage in rats [36]. Therefore, our results suggest that JAK/
STAT pathway may also serve as a potential target for early
intervention in ischemic acute renal failure.
Toll and NOD-like receptors. As observed in Figures 2 and
4, Toll-like (TLRs) and NOD-like receptors (NLRs) signaling
pathways were overrepresented after IRI and IPC+IRI. These
receptors, which recognize common molecular patterns, partici-
pate in the inflammatory response presented in acute and chronic
kidney diseases [37,38,39]. This activity is mediated by their
activation by endogenous ligands released from damaged tissues,
such as hyaluronan, fibronectin and heat shock proteins. Also,
renal tubular epithelial cells increase the expression of TLRs
during acute kidney injury [2]. We found that the TLR-2
expression was altered after IPC and that CD14 expression, a co-
receptor for TLR-4 signaling, was up-regulated after IRI and IPC.
TLR-4/CD14 signaling was already described as a cellular
sentinel for acute renal damage due to the activation of the
nuclear factor kB (NF-kB) inflammatory pathway [40], and genes
related to I-kappaB kinase/NF-kappaB cascade were up-regulated
after IRI (Table S6). This line of evidence suggests that the
inflammatory exacerbation promoted by TLR-4/CD14/NF-kB
signaling in the kidney may be prejudicial and, thus, these
pathways may be a good target to modulate. Moreover, the
comparison IRI+Hemin vs IRI revealed that TLR signaling
pathway was one of the overrepresented down-regulated biological
themes (Figure 5). This result highlights the relevance of this
signaling in the modulation of IRI by Hemin.
Apart from TLR, the participation of the NLR family in IRI is
not well established, although NOD-1 and NOD-2 proteins are
expressed in renal tubular epithelial cells after IRI [41].
Furthermore, another study showed that NOD-2 knockout mice
presents lower levels of serum creatinine, urea, pro-inflammatory
cytokines and chemokines, as well as smaller ischemic tubular
necrosis areas compared to wild type animals submitted to IRI
[42]. Hence, future studies must be performed to assess the
relevance of NLR signaling in IRI and to determine how these
receptors are connected with clinical worsening or improvement.
Pathways related to differentiation and
development. IRI, IPC and Hemin treatment promoted the
up-regulation of genes pertaining to cell differentiation and
development (Figures 2, 4, 5 and 6; Tables S6, S7, S8, S10, S12
and S14), highlighting their roles in stress-related events. Upon
kidney epithelial cells loss due to IRI, the surviving cells
dedifferentiate, migrate along the basement membrane, proliferate
to restore cell number and then differentiate, restoring the
nephron functional integrity [43]. Also interesting, molecules
which are expressed during kidney development but not in mature
nephron are enormously expressed in proximal tubules after IRI.
Although the relevance of the reversion to a less-differentiated cell
phenotype during IRI is not clear, such phenomenon must be well
understood, given its relevance for the progression to chronic
kidney disease.
Angiotensin II signaling pathway. The renin-angiotensin-
aldosterone system, especially the peptide Angiotensin II (Ang II),
contributes to kidney injury [44]. Genes belonging to this
biological theme were down-regulated in IRI vs Control and
IPC+IRI vs IRI comparisons (Figures 2 and 3, respectively). In
fact, one of the most down-regulated genes in IRI vs Control
(Table S1) was the receptor of Ang II AT1B. This shows the
kidney efforts to down-regulate AT1B expression and, hence, to
reduce the renal damage promoted by this receptor signal
transduction. Moreover, it is increasingly apparent that the
cross-talk between Ang II and other signals such as ErbB through
Figure 6. Top ranked biological functions after hemin treatment. A) KEGG categories showing significant enriched functions for differentially
expressed genes at Hemin vs Control comparison; B) Biological Process Ontology (GO) of the differentially expressed genes at Hemin vs Control
comparison. The bar plot represents the percentage of genes differentially expressed and functionally annotated in isolated kidney tissue. Bar plot
colors represent up (red) and down (green) regulated genes.
doi:10.1371/journal.pone.0049569.g006
Renal IRI Transcriptome
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corresponding receptors heterodimerization might play a crucial
role in renal deterioration and renal epithelial cell hypertrophy
[45,46]. Therefore, the down-regulation of Ang II receptors may
be also a response against this potentially harmful cross-talk.
Focal adhesion and ECM-receptor interaction. Focal
adhesion and ECM-receptor interaction were other two overrep-
resented themes observed from the differentially expressed genes
found after IRI (Figure 2). The interactions between cell and
extracellular matrix are mediated by the integrin family of cell
adhesion receptors at focal adhesions, which consist of a large
number of both cytoskeletal and signal transduction adapter
proteins [47]. Stress events like IRI can disorganize focal
adhesions by restructuring actin cytoskeleton and activating some
downstream kinases, such as ERK1/2, which causes focal
adhesion impairment and subsequent renal injury [48]. Here,
we found the up-regulation of genes that participate in focal
adhesion and ECM-receptor interaction functions such as CD44,
Tenascin and some integrins, which were already described in
kidney pathological conditions [49,50,51]. As molecules of
adhesion, they can be required to avoid massive tubule epithelial
cell detachment in response to ischemia, not allowing the
disassembly of focal adhesion complexes present in that context.
However, they can also promote other functions like cell fate
decision and lymphocyte extravasation to the injured local, with
the maintenance of a pro-inflammatory milieu within the ischemic
kidney [52]. Thus, the preservation of tubular epithelium integrity
and focal adhesion interactions that support this epithelium could
be an interesting therapeutic approach to maintain renal function
stabilized [53].
Regulation of actin cytoskeleton. Genes involved in the
regulation of actin cytoskeleton were up-regulated at IRI vs
Control (Figure 2, Table S6) and down-regulated in IRI+Hemin x
IRI (Figure 5, Table S13) and IPC+IRI vs IRI comparisons. Actin
cytoskeleton plays important roles in the structure and function of
proximal tubular epithelial cells through modulating cell-cell and
cell-extracellular matrix (ECM) adhesions. Ischemia remodels
filamentous actin, detaching proximal tubular epithelial cells,
which may lead in part to acute renal failure. Moreover, cellular
ATP depletion in diverse cell types results in the net conversion of
monomeric G-actin to polymeric F-actin, representing an impor-
tant aspect of cellular injury in the ischemic tissue. Among the
differentially expressed genes found, Rock2 was up-regulated in
IRI (Table S6), which participates of actin cytoskeleton polymer-
ization during ischemic conditions. Noteworthy, ROCK-inhibi-
tion by hydroxyfasudil was shown to significantly improve kidney
function in a rat model of acute renal IRI [54]. Also, we found that
Hemin treatment and ischemic pre-conditioning was capable of
down-regulating the expression of the gene coding for Profilin
(Pfn1). Pfn1 is an actin-binding protein involved in the mechanism
of actin polymerization in cellular ATP depletion [55]. Therefore,
the regulation of actin polymerization can be an important agenda
for future research into the protection against kidney impairment
function.
Wnt signaling pathway. Wnt signaling pathway genes were
differentially regulated in IPC+IRI vs IRI (Figure 3), IPC+IRI vs
Control (Figure 4, Table S10) and IRI +Hemin vs IRI (Figure 5,
Table S12) comparisons. This found may suggest that Wnt
signaling may play a relevant role in the renal protection caused by
IPC and Hemin manipulations. Indeed, it is increasingly apparent
that Wnt signaling is capable of protecting the kidney against
apoptosis by inhibiting Bax, Caspase 3 and Cytochrome c
activities, leading, at the end, to ischemic resistance [56,57]. In
contrast, other studies have associated Wnt signaling with the
progression of chronic renal allograft damage [58] and renal
fibrosis [59]. Perhaps paradoxically, this opposite effect observed
may be related to the context-dependency and complexity of this
pathway, undergoing many levels of cross-talk with other
regulatory pathways. Hence, the predictability of how Wnt
pathway modulation could influence renal IRI becomes tricky
[60]. Of note, previous studies have addressed the role of Wnt
signaling in preconditioning cardioprotection [61,62], corroborat-
ing the idea that some components of Wnt pathway are involved
in pro-survival mechanisms elicited by IPC.
Vascular events. Genes belonging to ‘‘Vascular smooth
muscle contraction’’ category were up-regulated at IRI+Hemin
vs IRI comparison (Figure 5, Table S12). A previous study has
demonstrated that Hmox1 knockout mice exhibited exacerbated
vascular lesions after ischemia/reperfusion [63] and their arteries
exhibited increased sensitivity to constrictors. Furthermore, it was
already demonstrated that hemin treatment improves microcircu-
lation by induction of Hmox1 in IRI after kidney transplantation
[64]. Therefore, Hmox1 may be important in the regulation of
vessels function in stress situations experienced by the kidney.
Hmox1 could neutralize vasoconstrictor mediators released within
IRI, counterbalancing detrimental consequences of these media-
tors to renal function. Also relevant, the IRI+Hemin vs IRI
comparison showed up-regulation of genes belonging to ‘‘Vascular
endothelial growth factor receptor signaling pathway’’ category
(Figure 5, Table S12), which may, in turn, help the kidney to avoid
persistent ischemia by promoting local angiogenesis.
Amino acid and nitrogen metabolism. Hemin treatment
enhanced the expression of genes involved in amino acids and
nitrogen metabolism (Tables 12 and 14; Figure 6). This finding
may indicate a mechanism of tolerance increasing to ischemia by
means of a metabolic adaptation through increased amino acid
metabolism. Interestingly, the administration of regulatory amino
acids such as phenylalanine, tryptophan and alanine showed
protective effects against ischemia in a model of hepatic ischemia
[65]. Thus, nitrogen metabolism may have a possible role to the
preservation of liver viability.
Identification of common and exclusively regulated genes
between the groups. A Venn diagram was constructed to
identify common and exclusively up-regulated genes by IRI, IPC
and Hemin treatment protocols (Figure 7A). We found that 136,
189 and 469 genes were exclusively expressed due to IPC,
IRI+Hemin or IRI conditions. Although a few genes were
commonly up-regulated between IRI vs control and the other
two comparisons described above, 108 genes were commonly
expressed between IPC x IRI and IRI+Hemin x IRI comparisons,
indicating possible common mechanisms between IPC and Hemin
maneuvers. The main common biological functions enriched were
transcription, DNA replication, DNA metabolic process, cell cycle,
regulation of microtubule polymerization/depolymerization, cen-
trosome organization and steroid hormone receptor signaling
pathway (Figure 7B). In contrast, data representing down-
regulated genes did not show a representative amount of
commonly differentially expressed genes (data not shown).
Figure 8 represents the functional enrichment analysis of the
exclusively expressed genes in IPC x IRI and IRI+Hemin x IRI
comparisons categorized by KEGG and GO. Noteworthy, IPC
exclusively induced the expression of genes involved in tight
junction, steroid hormone biosynthesis, NOD-like receptor
signaling pathway, proteolysis, response to stress and apoptosis,
microtubule cytoskeleton organization and cell migration. On the
other hand, Hemin pre-treatment was able to exclusively induce
the expression of genes related to metabolic pathways, vascular
smooth muscle contraction, arachidonic acid metabolism, regula-
tion of actin cytoskeleton, Wnt signaling pathway, retinol
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metabolism, Drug metabolism – Cytochrome P450, cell differen-
tiation, oxidation-reduction process, cell cycle, mitosis and MAPK
cascade.
Validation of microarray results using qRT-
PCR. Expression patterns of all selected genes (Table S15) used
for microarray validation were consistent with the values found
using qRT-PCR. Normalization was performed using the Hypo-
xanthine-guanine phosphoribosyltransferase (Hprt) housekeeping
gene. Figures 9, 10 and 11 represent the qRT-PCR results
confirming the consistency of microarray data. We found a good
correlation between microarray and qPCR results in the genes
evaluated (Pearson correlation coefficient, r =20.7849), which is
in accordance with other articles in the literature that showed
similar results [66,67,68]. Furthermore, the linear regression
analysis performed showed a p-value = 0.0005, indicating that
the slope of the regression line is significantly different from zero,
which in turns shows that there is a significant relationship
between ‘‘qPCR values’’ and ‘‘DNA microarray values’’ variables.
Conclusions
Ischemia/reperfusion injury is still a major clinical problem for
many kidney diseases, as well as the predominant insult in organ
transplantation. In the present work, we performed transcriptomic
analysis of the kidney response to IRI in a mice model of acute
kidney injury. Moreover, we compared IRI with two separate
interventions, ischemic preconditioning and treatment with
Hemin.
Our functional genomics approach revealed in an integrative
manner the differential transcriptome profiles and subsequent
enriched biological functions among the groups, providing a global
picture of how the kidney behaves after IRI. Although previous
works have already addressed differential gene expression follow-
ing IRI in animal models [69,70,71,72,73], these studies used
microarray sets containing much less probes than used here (44000
oligonucleotide probes corresponding to approximately 42000
transcripts). Consequently, many new relevant genes were found
in our study, updating the current information regarding
transcriptome regulation following IRI. Also, our findings were
consistent with these previous microarray studies, confirming the
participation of genes associated with apoptosis, inflammation,
extracellular matrix, stress response, growth factors, adhesion
molecules, proteases, etc. Noteworthy, a consistent part of the
differentially expressed genes observed in this work participates in
biological functions previously described to be protective against
IRI. Therefore, the kidney cells effort to induce a potential
protective transcriptome program after IRI was revealed.
Cells injured can release immunological pattern molecules
which are recognized by kidney and immunological cells, initiating
persistent inflammation. The exacerbation and spreading of
inflammatory mediators into other nephron regions may lead to
persistent injury of the system. Consonant with this idea,
inflammatory soluble mediators such as TGF-b, Angiotensin II
and EGF, which signals were described to be altered in our work,
may initiate some side effects into kidney. This might affect
angiostasis, cell reactions, fibrosis [74] and other pathophysiolog-
ical processes such as epithelial–mesenchymal transition process,
in which injured tubular cells trying to regenerate the renal system
recapitulate its development [75]. Accordingly, studies aiming to
tune these pathways may clarify in which conditions these signals
may cause an exacerbated damage response, depending on factors
such as time, site of release and specific mediators.
Hmox1 up-regulation was already described as a common
mechanism of protection afforded by Hemin and IPC in other
experimental models [64,76,77,78]. Hemin treatment is widely
known to induce Hmox-1 expression [11,19,79,80,81]. Moreover,
some recent papers have shown that, in different organs, the
protective effects of IPC are at least partially mediated via Hemox-
1 up regulation [82,83,84,85]. In addition, some studies showed
that the inhibition of Hmox-1 (either by pharmacologic inhibition
or with siRNA) causes the lost of the protective effects of IPC
[76,86], confirming once more the role of heme oxygenase-1
system in tissue recovery.
Beside the previous described mechanism, new insights were
also obtained about the underlying mechanisms involved in kidney
protection against IRI promoted by IPC and Hemin treatment.
Venn diagram analysis helped us to identify overlapping
differentially expressed genes, which may suggests, in turn,
potential common and different mechanisms involved in these
maneuvers (Figures 7 and 8). Both maneuvers were able to
modulate genes belonging to DNA replication, proliferation, cell
cycle, microtubule polymerization and centrosome organization.
Collectively, these results suggest that the up regulation of
pathways that facilitate cell recovery is occurring within kidney
tissue in both cases. Accordingly, one of the main pathways
overexpressed after Hemin treatment and IPC is the MAPK
signaling, which is involved in cell cycle division and, consequent-
ly, proliferation. As an example of this cascade, a recent paper
showed that when there is a pharmacological intervention that
leads to inhibition of MAPK signaling, the recovery after an acute
kidney injury episode is delayed [87].
Venn diagram analysis also showed us some possible exclusive
mechanisms between Hemin and IPC. IPC exclusively regulated
the expression of genes pertaining to protein modification
processes such as proteolysis, response to stress and regulation of
apoptosis. Therefore, the role of IPC in controlling exacerbated
stress response and consequently protein modifications and
apoptosis was highlighted. Finally, Hemin treatment exclusively
regulated the expression of genes associated with cell differenti-
ation, metabolic pathways, cell cycle, mitosis, development,
regulation of actin cytoskeleton and arachidonic acid metabolism,
suggesting a pleiotropic effect for Hemin.
We only tested in this work gene expression changes at 6 hours
interval. Thus, further studies to evaluate temporal gene expres-
sion of selected genes with biological relevance should be carried
out to confirm which changes are transient or durable. We found
relevant this time interval because unpublished data from our
laboratory showed that the peak of Hmox-1 expression occurs
around 6 hours after reperfusion, providing a reasonable evidence
that this time point should be the best to compare changes
between the groups shown in our manuscript. As we focused on
the transcriptome analysis, we believe that the chosen time point
may provide us essential information upon the molecular changes
on gene expression that will later interfere in the renal function
outcome, as observed by our group and others [10,88,89]. Also,
this temporal gene expression analysis could clarify some issues, as
many results in literature reveal opposite roles for the same signals,
Figure 7. Venn diagram of microarray results reveals similarities and differences in differential transcriptome profiles regulated by
IRI, IPC Hemin treatment protocols. A) Venn diagram visualizing the overlapping results between the differentially regulated genes found at IRI
vs Control, IRI+Hemin vs IRI and IPC+IRI vs IRI comparisons. B) Biological Process Ontology (GO) of the commonly differentially expressed genes found
at IPC+IRI vs IRI and IRI+Hemin vs IRI comparisons. The red color of the bar plots represent up-regulated genes.
doi:10.1371/journal.pone.0049569.g007
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Figure 8. Top ranked biological functions of the exclusively differentially expressed genes regulated by IPC and Hemin treatment. A)
KEGG categories showing significant functional enrichment of the exclusively differentially expressed genes found at IPC+IRI vs IRI and IRI+Hemin vs
IRI comparisons. B) Biological Process Ontology (GO) of the exclusively differentially expressed genes found at IPC+IRI vs IRI and IRI+Hemin vs IRI
comparisons. The red color of the bar plots represent up-regulated genes.
doi:10.1371/journal.pone.0049569.g008
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Figure 9. Validation of microarray results by qRT-PCR analysis. Expression of the genes Hmox-1 (A), Fosl1 (B) and Cxcl1 (C), were evaluated
by microarray and qRT-PCR experiments. In microarray experiments, values are represented by log2-transformed gProcessed signal. For qRT-PCT, the
relative RNA amounts were calculated using the comparative method 2-DDCT and Hprt as an internal control. Results are shown as Boxplot format
with whiskers from minimum to maximum values. *p,0.05 compared to Control.
doi:10.1371/journal.pone.0049569.g009
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with the duration of specific pathways shaping the switch between
one and another response [90].
Although the functional enrichment analysis used here was
helpful to identify possible relevant genes and pathways, a
limitation of the present study is that we were only able to detect
pathways whose genes are regulated by transcriptional activity.
However, other relevant targets that are not regulated at the
transcriptional level may have not been disclosed. These targets
could be possibly regulated metabolically, dependent on phos-
phorylation status or other indirect effects of IPC or hemin
treatment.
In summary, the functional transcriptional analysis conducted
in this work allowed the detection of new targets, biological
processes and signaling pathways associated with IRI and
renoprotective defenses. Further dissections of the molecular
mechanisms found here are demanding to gain potential insights
into the pathophysiological changes occurring in renal IRI.
Moreover, further studies evaluating the protection properties of
IPC and Hemin treatment may be an important agenda for the
discovery of effective treatments to ischemia-related kidney
diseases.
Materials and Methods
Animal and Surgical Procedures
Isogenic male C57BL/6 mice, age 8–12 wks (25–28 g), were
purchased from Federal University of Sa˜o Paulo (UNIFESP),
Brazil. All animals were housed in individual and standard cages
and had free access to water and food. All procedures were
previously reviewed and approved by the internal Ethics
Committee of the Institution (document number 118/2008).
Experimental Model of Renal IRI
Surgery was performed as previously described [91]. Briefly,
mice were anesthetized with Ketamine-Xylazine (Agribrands do
Brazil, Sa˜o Paulo, Brazil), a midline incision was made and both
renal pedicles were cross-clamped for 45 minutes. During the
procedure, animals were kept well hydrated with saline and at a
constant temperature (,37uC) through a heating pad device.
Subsequently, microsurgery clamps were removed, the abdomen
closed and animals placed in single cages, warmed by indirect light
until completely recovered from anesthesia. Animals were kept
under adjustable conditions until sacrifice, namely 6 hours after
renal reperfusion. In order to induce Hmox1 expression, mice
received Hemin (Frontier Scientific, Canada) i.p., 25 mg/kg, 24
hours prior to surgery. For ischemic preconditioning protocol,
mice were anesthetized and both renal pedicles were clamped for
15 minutes. After that, microsurgery clamps were removed and
animals were sutured. Mice were kept under adjustable conditions
for 7 days, and then they underwent standard renal IRI model (45
minutes of ischemia and sacrifice after 6 hours of reperfusion).
Analysis of Renal Function
Serum creatinine was used for evaluation of renal function.
Blood samples were collected at 6 hours post reperfusion from the
abdominal inferior cava vein immediately before induced death.
Serum samples were analyzed on a Cobas Mira Plus (Roche,
Mannhein, Germany), using the modified Jaffe´ technique. Groups
were statistically compared using one-way ANOVA followed by
Tukey’s post-hoc test with p,0.05.
RNA Extraction
Total RNA was isolated from kidney samples using Trizol
reagent (Life Technologies) and purified using RNeasy Spin
Columns (Qiagen, USA). RNA quantity was determined using a
Nanovue spectrophotometer (GE Healthcare, USA). The RNA
quality was performed using a 2100 Bioanalyzer with an RNA
6000 Nano kit and Ladder (Agilent Technologies, USA),
according to the manufacturer’s instructions. The Bioanalyzer
produces an electropherogram, which shows the distribution of
RNA transcripts in the sample. In an ideal sample, the two peaks
of the ribosomal RNA 18S and 28S bands are observed, while
additional peaks suggest RNA degradation and/or DNA contam-
ination. The 2100 Bioanalyzer Expert software program (version
B.02.06.SI418) assigns an RNA integrity number (RIN) from 1 to
10, with 1 =degraded and 10= intact (Schroeder et al, 2006).
Only samples with a RNA integrity number (RIN) of 8 or greater
were employed.
RNA Amplification and Labeling
Agilent’s Quick Amp Labeling Kit was used to generate
fluorescent cRNA (complementary RNA) for the microarray
hybridizations, following the manufacturer’s instructions. Briefly, a
700 ng aliquot of total RNA was reverse transcribed into cDNA.
Synthesized cDNA was transcribed into cRNA and labeled with
the fluorescent dye Cyanine 3 (Cy3). Labeled cRNA was purified
with RNeasy Mini columns (Qiagen). The quality of each cRNA
sample was verified by total yield and Cy3 specific activity
calculated based on Nanovue spectrophotometer measurements
(GE Healthcare).
Figure 10. Validation of microarray results by qRT-PCR analysis. Expression of the genes Ccl5 (A), Hoxd4 (B), Muc20 (C) and Socs3 (D) were
evaluated by microarray and qRT-PCR experiments. In microarray experiments, values are represented by log2-transformed gProcessed signal. For
qRT-PCT, the relative RNA amounts were calculated using the comparative method 2-DDCT and Hprt as an internal control. Results are shown as
Boxplot format with whiskers from minimum to maximum values. *p,0.05 compared to Control; **p,0.05 compared to IRI; ***p,0.05 compared to
Hemin.
doi:10.1371/journal.pone.0049569.g010
Figure 11. Linear regression analysis revealed a good degree
of correlation (R2 =0.6161) between oligonucleotide microar-
ray and quantitative RT-PCR. Horizontal axis, values obtained with
microarray experiments; vertical axis, values obtained with qRT-PCR.
doi:10.1371/journal.pone.0049569.g011
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Microarray Hybridization
Microarray hybridizations were carried out on labeled cRNAs
with Cy3 specific activity greater than 9 rmol Cy3 per mg of RNA.
Arrays were incubated at 65uC for 17 h in Agilent’s microarray
hybridization chambers and subsequently washed according to
Agilent’s one-color microarray-based gene expression analysis
protocol (Version 5.7, March 2008). Gene expression profiles were
evaluated using Agilent whole mouse genome 4644 K oligonu-
cleotide microarrays.
Data Acquisition
Hybridized slides were scanned at 5 mm resolution using an
Agilent G2505B DNA microarray scanner. Default settings were
modified to scan the same slide twice at two different sensitivity
levels (XDR Hi 100% and XDR Lo 10%). The two linked images
generated were analyzed together and data was extracted
subtracting the background using the standard procedures
contained in the Agilent Feature Extraction (FE) Software version
9.5.1. The software returns a series of spot quality measures to
assess the reproducibility and reliability of spot intensity estimates.
These parameters are summarized in a quality control report and
were evaluated in order to support the high quality of the data
acquired.
Data Processing and Analysis
The R statistical environment (http://www.r-project.org) was
used to filter the data. The mean of the probes for each gene was
calculated, genes with more than one missing value were removed
and then the signal intensities were log2 transformed. These
logarithmic values were input in the TM4 software suite in order
to perform the statistical analyses [92]. To identify which genes
were significantly differentially expressed, a statistical technique
called SAM (Significance Analysis of Microarrays) was used [93].
SAM assigns a score to each gene on the basis of a change in gene
expression relative to the standard deviation of repeated
measurements. For genes with scores greater than an adjustable
threshold, SAM uses permutations of the repeated measurements
to estimate the percentage of genes identified by chance – the false
discovery rate (FDR). Analysis parameters (Delta) were set to result
in zero FDR. Fold changes based on arbitrary selection criteria (3
or 4-fold change up or 2-fold change down) were applied to
identify only the genes whose expression was most affected during
the different protocols used here. Combinations of gene sets were
carried out using Gene List Venn Diagrams software [94]. The
complete data set is publicly available at the National Center for
Biotechnology Information (NCBI) Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo/) through the series accession
number GSE39548.
Functional Enrichment Analysis
Overrepresented biological functions were searched in the
differential gene expression datasets using FunNet (http://www.
funnet.info). FunNet is an integrative functional genomics tool that
performs a functional profiling of gene expression data, identifying
overrepresented biological themes [95]. FunNet exploits genomic
annotations provided by Gene Ontology (GO) and Kyoto
Encyclopedia of Genes and Genomes (KEGG) databases [96,97].
Validation of Microarray Results by Real-time PCR (qPCR)
To validate the results of microarray analysis, we confirmed by
qPCR the differential expression of some representative genes
using the same RNA samples that were used for microarray. First-
strand cDNA was synthesized from DNAse-treated total RNA
using Moloney Murine Leukemia Virus Reverse Transcriptase
(Promega, Wisconsin, US). We used Taqman-based quantitative
RT-PCR for validation of some of the genes identified by the
microarray analysis. The comparative method 22DDCT was used
for relative quantification of gene transcription between the
studied groups [98] and gene expression levels were normalized to
Hprt gene. Predesigned Taqman primers (Life Technologies) were
used for the validation. The list of genes validated by qRT-PCT
with the corresponding probe numbers are presented in Table
S15. DNA microarray and qRT-PCR results were subjected to
linear regression analysis and the Pearson coefficient correlation
was calculated to verify the degree of correlation between these
two methodologies using GraphPad PrismH 5. ANOVA one way
with Tukey’s post hoc test or Student’s t-test were performed to
verify significant differences between the groups in microarray and
qRT-PCR results. For all tests, statistical significance was
established as a P value of ,0.05.
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